UTROGESTAN

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug UTROGESTAN contains one active pharmaceutical ingredient (API):

1 Progesterone (micronized) UNII 4G7DS2Q64Y - PROGESTERONE

Progesterone is a natural progestogen, the main hormone of the corpus luteum and the placenta. It acts on the endometrium by converting the proliferating phase to the secretory phase. Read about Progesterone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
UTROGESTAN Capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03DA04	Progesterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DA Pregnen (4) derivatives
Discover more medicines within G03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10930G, 12598C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 542213020000014, 542213020000114, 542215030000603
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1581-MEE-1215, 1582-MEE-1215, 29625-02-11
Country: EE	Ravimiamet	Identifier(s): 1703944, 1781715, 1781726, 1809660, 1818671, 1823318, 1847370, 1847381, 1849877
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60814, 64899
Country: FR	Base de données publique des médicaments	Identifier(s): 61673424, 63157698
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 117590, 226768
Country: HK	Department of Health Drug Office	Identifier(s): 34020, 61091
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-677297904, HR-H-957395225, HR-H-979088283
Country: IE	Health Products Regulatory Authority	Identifier(s): 58492
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2902, 4728
Country: JP	医薬品医療機器総合機構	Identifier(s): 2477700H1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1090521, 1090522
Country: MT	Medicines Authority	Identifier(s): MA727/00205, MA727/00501, PI1438/00701A, PI908/22301A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 188M93
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 198366, 29181
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13679, 17513
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100412142, 100458655, 100462951, 100468073, 100468731
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W12320001, W42276001, W42276002, W42276003, W42276004
Country: SG	Health Sciences Authority	Identifier(s): 11437P, 15475P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5173031, 5173032
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/21.8.2/0215, A40/21.8.2/0771